Login / Signup
Challenges and Opportunities: Using Omics to Generate Testable Insights Into Pathogenic Mechanisms in Preclinical Seropositive Rheumatoid Arthritis.
V Michael Holers
Published in:
Arthritis & rheumatology (Hoboken, N.J.) (2020)
Keyphrases
</>
rheumatoid arthritis
disease activity
single cell
cell therapy
interstitial lung disease
ankylosing spondylitis
stem cells
systemic lupus erythematosus
idiopathic pulmonary fibrosis
bone marrow